Consistent with this finding, the depletion of PARG expression is observed in PARPis resistant triple-negative breast cancers and serous ovarian cancers [60], suggesting that the loss of PARG leads to PARPi resistance. The gene discussed is PARG; the disease is ovarian serous adenocarcinoma.